Literature DB >> 8811281

Selenium status is decreased in patients with intrinsic asthma.

J Kadrabová1, A Mad'aric, Z Kovaciková, F Podivínsky, E Ginter, F Gazdík.   

Abstract

Lowered selenium (Se) status has been observed in asthma patients. An increased production of reactive oxygen species (ROS) owing to inflammatory condition has also been found in these patients and thus antioxidant properties of Se via glutathione peroxidase (GPx) activity are of great importance. Concentrations of Se in plasma and erythrocytes as well as erythrocyte GPx activity in 22 intrinsic asthma patients (five patients; all women were aspirin-sensitive) were compared with those of 33 control subjects. Se concentrations in both plasma and erythrocytes and GPx activity were decreased in intrinsic asthma patients. There were no significant differences in investigated parameters of Se status between aspirin-tolerant and aspirin-intolerant patients within intrinsic asthma group. Significantly high positive correlation between plasma and erythrocyte Se concentrations was found when regarding all subjects as a whole. Se supplementation might be beneficial to patients with intrinsic asthma, which may be at risk of Se deficiency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811281     DOI: 10.1007/BF02789165

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  29 in total

Review 1.  Mechanism of action of biological antioxidants.

Authors:  N I Krinsky
Journal:  Proc Soc Exp Biol Med       Date:  1992-06

Review 2.  The pathophysiological significance of lipid peroxidation in oxidative cell injury.

Authors:  D L Tribble; T Y Aw; D P Jones
Journal:  Hepatology       Date:  1987 Mar-Apr       Impact factor: 17.425

3.  Oxidative metabolism and severe asthma in children.

Authors:  J M Malvy; Y Lebranchu; M J Richard; J Arnaud; A Favier
Journal:  Clin Chim Acta       Date:  1993-09-17       Impact factor: 3.786

4.  Lowered platelet glutathione peroxidase activity in patients with intrinsic asthma.

Authors:  L Hasselmark; R Malmgren; G Unge; O Zetterström
Journal:  Allergy       Date:  1990-10       Impact factor: 13.146

5.  Reduced selenium status of patients with asthma.

Authors:  J Stone; L J Hinks; R Beasley; S T Holgate; B A Clayton
Journal:  Clin Sci (Lond)       Date:  1989-11       Impact factor: 6.124

6.  Increased generation of the arachidonic metabolites LTB4 and 5-HETE by human alveolar macrophages in patients with asthma: effect in vitro of nedocromil sodium.

Authors:  M Damon; C Chavis; J P Daures; A Crastes de Paulet; F B Michel; P Godard
Journal:  Eur Respir J       Date:  1989-03       Impact factor: 16.671

7.  Selenium concentration in plasma and erythrocytes in a healthy Slovak population.

Authors:  A Madaric; J Kadrabová; E Ginter
Journal:  J Trace Elem Electrolytes Health Dis       Date:  1994-03

Review 8.  Sulphidopeptide leukotrienes in asthma.

Authors:  T H Lee; S P O'Hickey; C Jacques; R J Hawksworth; J P Arm; P Christie; B W Spur; A E Crea
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1991

9.  [Changes in free radicals and possibility of their correction in patients with bronchial asthma].

Authors:  S Boljevic; I G Daniljak; A H Kogan
Journal:  Vojnosanit Pregl       Date:  1993 Jan-Feb       Impact factor: 0.168

10.  Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge.

Authors:  U R Juergens; S C Christiansen; D D Stevenson; B L Zuraw
Journal:  J Allergy Clin Immunol       Date:  1992-10       Impact factor: 10.793

View more
  17 in total

1.  Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma.

Authors:  L G Wood; D A Fitzgerald; P G Gibson; D M Cooper; M L Garg
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

Review 2.  Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.

Authors:  Anne M Fitzpatrick; Dean P Jones; Lou Ann S Brown
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

Review 3.  The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities.

Authors:  Zhi Huang; Aaron H Rose; Peter R Hoffmann
Journal:  Antioxid Redox Signal       Date:  2012-01-09       Impact factor: 8.401

4.  Freeze-dried targeted mannosylated selenium-loaded nanoliposomes: development and evaluation.

Authors:  Susanne R Youngren; Rohit Mulik; Byoung Jun; Peter R Hoffmann; Kenneth R Morris; Mahavir B Chougule
Journal:  AAPS PharmSciTech       Date:  2013-09       Impact factor: 3.246

Review 5.  Selenium and asthma.

Authors:  Robert L Norton; Peter R Hoffmann
Journal:  Mol Aspects Med       Date:  2011-10-15

Review 6.  Dietary factors and the development of asthma.

Authors:  Augusto A Litonjua
Journal:  Immunol Allergy Clin North Am       Date:  2008-08       Impact factor: 3.479

Review 7.  Modulatory effects of selenium and zinc on the immune system.

Authors:  M Ferencík; L Ebringer
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

8.  Selenium deficiency alters epithelial cell morphology and responses to influenza.

Authors:  I Jaspers; W Zhang; L E Brighton; J L Carson; M Styblo; M A Beck
Journal:  Free Radic Biol Med       Date:  2007-03-24       Impact factor: 7.376

Review 9.  Selenium supplementation for asthma.

Authors:  M F Allam; R A Lucane
Journal:  Cochrane Database Syst Rev       Date:  2004

10.  Role of selenium and zinc in the pathogenesis of food allergy in infants and young children.

Authors:  Barbara Kamer; Wojciech Wąsowicz; Konrad Pyziak; Anna Kamer-Bartosińska; Jolanta Gromadzińska; Renata Pasowska
Journal:  Arch Med Sci       Date:  2012-12-19       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.